Healthcare -
Biotechnology - NASDAQ - US
$ 2.12
10.4 %
$ 147 M
Market Cap
-0.68
P/E
IKT - OTHER OPERATING ACTIVITIES
Other Operating Activities IKT - Inhibikase Therapeutics, Inc.
31.5 K
LAST VALUE
-79.10%
2 YEAR CAGR
-46.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR